PharmSciRN: Pharmacoeconomics (Topic)最新文献

The Innovative Pharmaceutical Manufacturing Industry: Driving Economic Growth 创新医药制造业:推动经济增长

PharmSciRN: Pharmacoeconomics (Topic) Pub Date : 2017-09-01 DOI: 10.2139/ssrn.3045191

N. Pham

引用次数: 0

To Study the Major Factors that Influence the Prescription Pattern of Doctors 探讨影响医生处方模式的主要因素

PharmSciRN: Pharmacoeconomics (Topic) Pub Date : 2014-08-26 DOI: 10.2139/SSRN.2487031

S. Joshi

{"title":"To Study the Major Factors that Influence the Prescription Pattern of Doctors","authors":"S. Joshi","doi":"10.2139/SSRN.2487031","DOIUrl":"https://doi.org/10.2139/SSRN.2487031","url":null,"abstract":"Pharmaceutical marketing is unique as the decision making of buying the medicine lies in the hand of intermediate customer (doctor) rather than final consumer (patient). Thus pharmaceutical companies try to influence the customer (doctor) rather than final consumer (Patient). Thus doctors are the most important players in pharmaceutical marketing system. Doctors write the prescriptions that determine which drugs (brands) will be used by the consumer (patient). Thus influencing the doctor is a key to the pharmaceutical sales. Pharmaceutical companies try to influence prescription pattern of doctors in favor of their brands by offering various kinds of promotional inputs. Doctor’s relationship with pharmaceutical companies is receiving a good attention since last few years. The reason being that the pharmaceutical marketing of branded formulation start and ends at doctor’s place. The ever increasing number of companies, molecules and brands will force the companies to have a good bonding with doctors. This bonding will come by fulfilling the customer’s desire by giving exactly what he/ she wants in terms of knowledge, communication, and updates on recent innovations. In this study the researcher have made an effort to understand the same. If industry understands how to satisfy their customer it will helpful for developing a long lasting relationship with their customer. The purpose of the study is to develop a simple framework for finding out the impact of the different kind of promotional tools offered by pharmaceutical industry on the prescribing behavior of doctors.","PeriodicalId":309667,"journal":{"name":"PharmSciRN: Pharmacoeconomics (Topic)","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131547030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Quality-Adjusted Price Index for Colorectal Cancer Drugs 结直肠癌药物的质量调整价格指数

PharmSciRN: Pharmacoeconomics (Topic) Pub Date : 2009-07-01 DOI: 10.3386/W15174

Claudio Lucarelli, S. Nicholson

引用次数: 28

Regulation of Health Related Nano Applications in India: Exploring the Limitations of the Current Regulatory Design 印度卫生相关纳米应用的监管:探索当前监管设计的局限性

PharmSciRN: Pharmacoeconomics (Topic) Pub Date : 2008-05-15 DOI: 10.2139/ssrn.1105685

Nidhi Srivastava, N. Chowdhury

{"title":"Regulation of Health Related Nano Applications in India: Exploring the Limitations of the Current Regulatory Design","authors":"Nidhi Srivastava, N. Chowdhury","doi":"10.2139/ssrn.1105685","DOIUrl":"https://doi.org/10.2139/ssrn.1105685","url":null,"abstract":"The burgeoning generic drugs and pharmaceuticals sector in India is one of the foremost industrial sectors of the new economy in India along with the IT sector. The growing manufacturing capacity of the health sector in concomitants with the aggressive international expansion strategies through mergers and acquisitions have meant that increasing investment in core R & D activities. Industry leaders as well as commentators have reiterated the need to invest in R & D activities especially focusing on harnessing new and emerging technologies like nanotechnology in improving current drug delivery systems and other health related products. This trend is also partly a response to the government policy that supports and incentivises the fundamental research and application of emerging technologies. This has been followed by consequent proliferation of nanotechnology R & D and application in pharmaceuticals and other related sectors, such as cosmetics, directly impacting health. Nanotechnology applications in drugs and equipment have the potential to have a huge impact on healthcare in India. Recently, nano particle drug delivery system in the form of nanotech-based chemotherapy has been introduced in the Indian markets.","PeriodicalId":309667,"journal":{"name":"PharmSciRN: Pharmacoeconomics (Topic)","volume":"112 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114496694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6